Davidson Capital Management Inc. Pfizer Inc Transaction History

Davidson Capital Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $892,809 - $1.16 Million	-34,168 Reduced 99.74%	90 $2,000
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $4,332 - $5,063	-135 Reduced 0.39%	34,258 $1.14 Million
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $21,166 - $24,488	586 Added 1.73%	34,393 $1.26 Million
Q1 2023 May 01, 2023	BUY	$39.39 - $51.28 $699,605 - $910,784	17,761 Added 110.69%	33,807 $1.38 Million
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $669,920 - $874,507	16,046 New	16,046 $822,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Davidson Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Davidson Capital Management Inc. with notifications on news.